OXFORD--Wyeth-Ayerst Research has signed a deal with Oxford Molecular Group to license and install Oxford's RS3 Discovery client/server information management system enterprise-wide. According to Oxford, the pharmaceutical company will use the system for chemical registration, structure and substructure searching, and integrating biological assay data through a common Oracle-RS3 Discovery server.
Wyeth-Ayerst Opts For Oxford Molecular's RS3 Discovery System
Dec 22, 1998
Premium
Filed under
What's Popular?